CagriSema , the combination of cagrilintide and semaglutide, is another development showing promise, as detailed in the CagriSema dosing guide
Research documents superior efficacy compared to semaglutide, insulin glargine, and all other diabetes medications in head-to-head trials
Some patients taking a GLP-1 medication have experienced hair loss while on the therapy
Maximizing Your Results Without Alternating If you are tempted to alternate medications because your weight loss has slowed down, there are several evidence-based ways to reignite your progress without compromising your safety
The FDA addressed compounded versions of tirzepatide in its advisory, stating that it does not intend to take action against compounders in the immediate aftermath of this update as long as the products are not of a substandard quality or otherwise unsafe. After a period of 60 or 90 days, depending on the party in question, the FDA will no longer turn the other cheek when it comes to targeting companies caught distributing compounded versions of this popular drug.